Original Article COMPARATIVE ANALYSIS OF STAGING MODALITIES IN CARCINOMA STOMACH: UNRAVELING THE SYNERGY BETWEEN STAGING LAPAROSCOPY AND CECT ABDOMEN ABHINAV CHAUDHARY 1 , MANISH YADAV 2 , ARVIND KANWAR 3* , PARIKSHIT MALHOTRA 4 , UK CHANDEL 5 1 Department of Surgery, Dr RPGMC, Tanda, Himachal Pradesh, India. 2,3 Department of Surgery, Dr YSPGMC Nahan, Himachal Pradesh, India. 4 Department of Surgery, SLBSGMC Nerchowk, Himachal Pradesh, India. 5 Department of Surgery, IGMC Shimla, Himachal Pradesh, India * Corresponding author: Arvind Kanwar; * Email: kanwar.ak.arvind@gmail.com Received: 20 Dec 2023, Revised and Accepted: 24 Jan 2024 ABSTRACT Objective: Stomach carcinoma, a complex challenge in oncology, necessitates refined staging for optimal therapeutic strategies. The comparative analysis of staging laparoscopy and contrast-enhanced computed tomography (CECT) emerges as a key exploration in this context. Methods: Conducted at Indira Gandhi Medical College and Hospital, Shimla, this prospective study spanned one year. Biopsy-proven gastric carcinoma patients meeting inclusion criteria underwent extensive investigations, including CECT, staging laparoscopy, and diagnostic lavage. The study employed specific protocols for each procedure, ensuring comprehensive data collection. Results: Analysis of 32 cases revealed a prevalence in the 61-70 y age group, predominantly affecting males. Diverse symptoms included pain (68.75%) and palpable mass (81.2%). Well-differentiated adenocarcinoma (43.8%) dominated, with distinct age-related patterns. The study showcased the intricate nature of gastric carcinoma, demanding tailored diagnostic approaches. Conclusion: This study unravels the interplay between staging laparoscopy and CECT in gastric carcinoma, offering a comprehensive staging approach. The nuanced insights gained through their synergy address individual limitations, contributing to more precise evaluations and tailored interventions. The collaborative use of these modalities promises to enhance precision, ultimately improving patient outcomes in gastric carcinoma management. Keywords: Stomach carcinoma, Staging laparoscopy, Contrast-enhanced computed tomography, Diagnostic modalities, Personalized treatment, Gastric cancer management © 2024 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (https://creativecommons.org/licenses/by/4.0/) DOI: https://dx.doi.org/10.22159/ijcpr.2024v16i2.4047 Journal homepage: https://innovareacademics.in/journals/index.php/ijcpr INTRODUCTION Stomach carcinoma, a formidable adversary in the landscape of oncology, demands a comprehensive understanding of its intricate nature to devise optimal therapeutic strategies. The quest for refining diagnostic methodologies in the face of this complex disease progression has led to an exploration of innovative staging techniques, and among these, the dynamic interplay between staging laparoscopy and Contrast- Enhanced Computed Tomography (CECT) of the abdomen emerges as a focal point for scrutiny [1]. This article endeavors to conduct a thorough comparative analysis of these staging modalities, unraveling the intricate synergy that exists between staging laparoscopy and cect abdomen in the context of carcinoma stomach [2]. The challenges inherent in managing stomach carcinoma are multifaceted, given the diversity of clinical presentations and the complex trajectory of disease progression. Accurate staging is pivotal, acting as the linchpin for determining the most appropriate and effective treatment strategy [3]. As the medical community endeavors to refine and enhance staging methodologies, the integration of innovative techniques becomes paramount. In this regard, the comparative analysis of staging laparoscopy and cect abdomen presents a compelling avenue for exploration, holding the promise of providing deeper insights into the disease and revolutionizing the approach to staging [4]. Staging laparoscopy, traditionally reserved for exploratory purposes, has evolved into an indispensable adjunctive staging method. This minimally invasive surgical procedure offers unparalleled insights into the peritoneal cavity, facilitating the identification of metastatic lesions that might elude conventional imaging [5]. The systematic inspection of the entire abdominal cavity and targeted biopsies make staging laparoscopy a valuable tool for a more personalized and targeted approach to treatment. Contrastingly, cect of the abdomen has long stood as a cornerstone in the staging process, providing detailed anatomical information through cross-sectional imaging. However, its limitations in detecting subtle peritoneal metastases and small locoregional lesions have prompted the exploration of complementary modalities [6]. This comparative analysis seeks to unravel the intricacies of the synergistic relationship between staging laparoscopy and cect abdomen. By delving into their respective strengths, limitations, and combined efficacy, the article aims to provide a nuanced understanding of how these modalities can complement each other to enhance the precision of stomach carcinoma staging. The examination of recent studies, technological advancements, and clinical outcomes will contribute to shedding light on the evolving role of staging laparoscopy when employed in conjunction with cect abdomen [7]. As we navigate through this exploration, the goal is not only to present a comparative analysis but also to contribute valuable perspectives to the ongoing discourse in oncology. By fostering a deeper understanding of the synergy between staging laparoscopy and cect abdomen, this article aspires to catalyze advancements that can translate into improved patient care and outcomes in the realm of stomach carcinoma management [8]. MATERIALS AND METHODS Study setup and design  Study Area: The study was conducted in the Department of Surgery at Indira Gandhi Medical College and Hospital, Shimla.  Study Duration: The study spanned a period of one year.  Study Description: This was a prospective study. Study population  The study included patients with biopsy-proven gastric carcinoma in the Department of Surgery, IGMC, Shimla, who met the inclusion criteria. International Journal of Current Pharmaceutical Research ISSN- 0975-7066 Vol 16, Issue 2, 2024